Patent: 8,551,980

Try a free trial See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,551,980

Title:	Substituted triazolopyridines
Abstract:	The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors: Formula (I), in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis proliferative of diseases, as well as to intermediate compounds useful in the preparation of said compounds. ##STR00001##
Inventor(s):	Schulze; Volker (Bergfelde, DE), Koppitz; Marcus (Berlin, DE), Kosemund; Dirk (Berlin, DE), Bader; Benjamin (Berlin, DE), Lienau; Philip (Berlin, DE), Briem; Hans (Berlin, DE), Holton; Simon (Berlin, DE), Siemeister; Gerhard (Berlin, DE), Prechtl; Stefan (Berlin, DE), Wengner; Antje Margret (Berlin, DE)
Assignee:	Bayer Intellectual Property GmbH (Monheim, DE)
Application Number:	13/512,737
Patent Claims:	see list of patent claims

Details for Patent 8,551,980

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Genentech	RITUXAN	rituximab	VIAL	103705	001	1997-11-26	➤ Sign Up	Bayer Intellectual Property GmbH (Monheim, DE)	➤ Sign Up	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patent Family for US Patent 8,551,980

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
World Intellectual Property Organization (WIPO)	2011063907	Jun 03, 2011
United States of America	2012328611	Dec 27, 2012
Japan	2013512263	Apr 11, 2013
Japan	5805652	Nov 04, 2015
Hong Kong	1180333	Mar 24, 2017
Spain	2439776	Jan 24, 2014
Country	Patent Number	Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.